LIVE WEBCAST | Minimizing the Impact of Human Error, Subjectivity, and Labor Costs: The Application of Digital Pathology in Clinical Trials

Join Proscia and Thermo Fisher Scientific in a live webcast hosted by Applied Clinical Trials for a discussion on the use of digital pathology by life science organizations, from the creation of centralized, digital labs to the automation of the most subjective and error-prone processes. 

The webinar will take place on Tuesday, March 19 at 11AM ET.

Register here

Event Overview

The complexities of running global-scale clinical trials require an expensive, error-prone, and labor-intensive operation. Digital pathology is changing that. Learn how some CROs and pharmaceutical companies have digitized their pathology operations and incorporated these best practices to drive consistency, quality, and efficiency across the laboratory. This is a must-attend event for any life science organization looking to incorporate pathology data more meaningfully to drive insightful, impactful R&D.

Key Learning Objectives
• What are the main sources of error and subjectivity in clinical trials?
• What are the key benefits of digital pathology for commercial research?
• What does it mean to have a centralized lab?
• What should I look for in a digital pathology solution?

Speakers:
• Ashley Murgatroyd, Product Manager at Proscia
• Christopher Coley, Commercial Marketing Manager, Digital Pathology at Thermo Fisher Scientific

Who Should Attend?
This webcast is designed for anyone working at a pharma, biotech, or CRO who is interested in digital pathology. Specific titles and keywords might include:

• CXO
• Pathology
• Clinical Trials
• Imaging
• Medical Director
• Scientist
• Researcher
• Lab Informatics
• Pre-Clinical / Clinical Research

Source: Proscia, Thermo Fisher Scientific, Applied Clinical Trials